Dallas, TX -- (SBWire) -- 06/29/2011 --GBI Research, the leading business intelligence provider, has released its latest research, “Technology Transfer Strategies – A Guide to Maximizing Returns Within the Pharmaceutical and Biopharmaceutical Industries”, which provides insights into global technology transfer strategies landscape.
The report explores the recognized and increasing need for a better understanding between all stakeholders in the biopharmaceutical and pharmaceutical community concerning the efficient transfer of technologies created from early innovative research to the commercialization of new product technologies. The report introduces the concept of technology transfer and the organizational reasons for opting on technology transfer along with the major technologies transferred. It also provides the commercial and scientific advantages along with the analysis of challenges and issues concerning intellectual property management. It also touches upon the use of licensing in technology transfer and reviews the background to licensing. The report also analyzes the strategic options available to the biopharmaceutical and pharmaceutical industry and also predicts the future trends for technology transfer within the industry. In the last chapter, the report also analyzes the key issues concerning the technology transfer regulations and specific legislation relating to the transfer of technology in the emerging countries of Brazil, Russia, India and China.
Scope
The scope of this report includes -
Detailed overview of technology transfer landscape which includes reasons, types, the process, challenges and critical issues.
Commercial and scientific advantages and benefits of technology transfer.
Different intellectual property management strategies in the current technology transfer landscape.
Adoption, rationale, duration and termination of licensing agreements for technology transfer.
Future opportunities and challenges with respect to technology transfer in the pharmaceutical industry along with geographic trends covering the US, Europe and Japan.
Technology transfer legislation and regulation in the emerging markets of Brazil, Russia, India and China which also includes technology transfer process, policies, challenges, trends, funding implications and case studies.
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
Formulate better strategies to enhance your competitive positioning in the technology transfer market by overcoming the major challenges and critical issues
Improve your product portfolio by identifying the key technologies and its benefits for developing better products
Negotiate better licensing agreements to in-license or out-license breakthrough technologies that can boost the development of innovative products
Device a more tailored country strategy through the understanding of key opportunities and challenges in the global technology transfer landscape.
Develop better market-entry and market expansion strategies for the high growth emerging economies.
Buy Now: Technology Transfer Strategies Market
http://www.reportsnreports.com/reports/83541-technology-transfer-strategies-a-guide-to-maximizing-returns-wi.html
Browse All: GBI Research Market Research Reports
http://www.reportsnreports.com/publisher/gbi-research/
About ReportsnReports
ReportsnReports is an online library of over 75,000 market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: +1-888-989-8004
E-mail: sales@reportsnreports.com
Website: http://www.reportsnreports.com
Technology Transfer Strategies – A Guide to Maximizing Returns Within the Pharmaceutical and Biopharmaceutical Industries
Report SummaryGBI Research, the leading business intelligence provider, has released its latest research, Technology Transfer Strategies - A Guide to Maximizing Returns Within the Pharmaceutic...